rs6717213

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001164507.2(NEB):​c.10707G>A​(p.Lys3569=) variant causes a synonymous change. The variant allele was found at a frequency of 0.0391 in 1,613,874 control chromosomes in the GnomAD database, including 3,640 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.084 ( 1073 hom., cov: 31)
Exomes 𝑓: 0.034 ( 2567 hom. )

Consequence

NEB
NM_001164507.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.97
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 2-151619616-C-T is Benign according to our data. Variant chr2-151619616-C-T is described in ClinVar as [Benign]. Clinvar id is 129762.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.206 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NEBNM_001164507.2 linkuse as main transcriptc.10707G>A p.Lys3569= synonymous_variant 73/182 ENST00000427231.7
NEBNM_001164508.2 linkuse as main transcriptc.10707G>A p.Lys3569= synonymous_variant 73/182 ENST00000397345.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NEBENST00000397345.8 linkuse as main transcriptc.10707G>A p.Lys3569= synonymous_variant 73/1825 NM_001164508.2 P5P20929-2
NEBENST00000427231.7 linkuse as main transcriptc.10707G>A p.Lys3569= synonymous_variant 73/1825 NM_001164507.2 A2P20929-3
NEBENST00000409198.5 linkuse as main transcriptc.9978G>A p.Lys3326= synonymous_variant 70/1505 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.0834
AC:
12685
AN:
152090
Hom.:
1058
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.0625
Gnomad AMR
AF:
0.0456
Gnomad ASJ
AF:
0.0639
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.122
Gnomad FIN
AF:
0.0165
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0181
Gnomad OTH
AF:
0.0778
GnomAD3 exomes
AF:
0.0556
AC:
13836
AN:
248946
Hom.:
920
AF XY:
0.0561
AC XY:
7576
AN XY:
135026
show subpopulations
Gnomad AFR exome
AF:
0.218
Gnomad AMR exome
AF:
0.0214
Gnomad ASJ exome
AF:
0.0612
Gnomad EAS exome
AF:
0.168
Gnomad SAS exome
AF:
0.115
Gnomad FIN exome
AF:
0.0153
Gnomad NFE exome
AF:
0.0178
Gnomad OTH exome
AF:
0.0409
GnomAD4 exome
AF:
0.0344
AC:
50338
AN:
1461666
Hom.:
2567
Cov.:
33
AF XY:
0.0363
AC XY:
26422
AN XY:
727116
show subpopulations
Gnomad4 AFR exome
AF:
0.222
Gnomad4 AMR exome
AF:
0.0239
Gnomad4 ASJ exome
AF:
0.0640
Gnomad4 EAS exome
AF:
0.166
Gnomad4 SAS exome
AF:
0.112
Gnomad4 FIN exome
AF:
0.0148
Gnomad4 NFE exome
AF:
0.0177
Gnomad4 OTH exome
AF:
0.0531
GnomAD4 genome
AF:
0.0838
AC:
12756
AN:
152208
Hom.:
1073
Cov.:
31
AF XY:
0.0845
AC XY:
6290
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.210
Gnomad4 AMR
AF:
0.0455
Gnomad4 ASJ
AF:
0.0639
Gnomad4 EAS
AF:
0.167
Gnomad4 SAS
AF:
0.123
Gnomad4 FIN
AF:
0.0165
Gnomad4 NFE
AF:
0.0181
Gnomad4 OTH
AF:
0.0884
Alfa
AF:
0.0361
Hom.:
635
Bravo
AF:
0.0897
Asia WGS
AF:
0.183
AC:
635
AN:
3478
EpiCase
AF:
0.0183
EpiControl
AF:
0.0211

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxFeb 18, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015p.Lys3569Lys in exon 73 of NEB: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 19.7% (795/4026) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs6717213). -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 19, 2023- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Nemaline myopathy 2 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
12
DANN
Benign
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6717213; hg19: chr2-152476130; COSMIC: COSV51419744; COSMIC: COSV51419744; API